bhakti hansoti joins us, professor of associate medicine.armaceutical company just stated this is trending towards endemic. for amateurs like me, that says all clear. are we all clear on covid? bhakti: absolutely not all clear, absolutely not and he endemic -- and not endemic. tom: it is radio and tv so you have to give longer answers. [laughter] the leader of new zealand said we still have a challenge here and a problem. we all know each and every story. how far are we from what the ceo of astrazeneca was talking about? bhakti: we are still in the midst of a pandemic which means we don't know how to overcome the current version of the disease from the virus. there are still daily deaths and daily limitations. we have some strategies we know to be effective such as social distancing and vaccinating. that has proven to not be enough. the virus continues to evolve. we have been very fortunate so far. it has been a couple of month since delta emerged. lisa: i'm concerned as i look at the numbers. even in areas where there are high vaccination r

bhakti hansoti from johns hopkins. lisa: 30%.of long covid and burnout when we saw the images of packed emergency rooms. i can imagine that over in germany, emergency rooms, the morale is dropping as they see another way of continuing. jonathan: these issues are not going away. tom: they are not going away. mayor bill de blasio talking about having a fully attended times square. what i find fascinating is in america, private enterprise will adapt and adjust the conversation. i am not trying to protect what they will do with the airlines or whatever, but you have to watch private enterprise reaction if this goes on. we are 19 months into it. jonathan: will you be in times square? will you attend that one? tom: i was there five years straight. jonathan: did you enjoy that? tom: no. jonathan: where did you go to the bathroom? it sounds terrible to me. lisa: people wear diapers. jonathan: that is what i was alluding to. lisa: [laughter] jonathan: tom keene, lisa abramowicz and jonathan ferro. coming up shortly from the bloomberg new